Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 152

Results For "TN"

3018 News Found

EnginZyme produces key mRNA vaccine ingredient using biocatalysis
Biotech | October 30, 2023

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines


Mandaviya inaugurates Rural Health Training Centre (RHTC) Hospital in Najafgarh, Delhi
Healthcare | October 26, 2023

Mandaviya inaugurates Rural Health Training Centre (RHTC) Hospital in Najafgarh, Delhi

RHTC will address a long-standing healthcare access issue for all the local population


Nanoform grant global starmap AI license to AstraZeneca
Digitisation | October 25, 2023

Nanoform grant global starmap AI license to AstraZeneca

Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening


ERS Genomics completes licensing agreement with Syngene International
News | October 23, 2023

ERS Genomics completes licensing agreement with Syngene International

Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners


KKR to invest in life sciences firm Catalio Capital Management
News | October 23, 2023

KKR to invest in life sciences firm Catalio Capital Management

Investment is additive to KKR’s existing health care growth strategy


Mandaviya convenes meeting to reiterate the nation’s commitment to addressing gender inequality
Policy | October 21, 2023

Mandaviya convenes meeting to reiterate the nation’s commitment to addressing gender inequality

Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20


Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr
News | October 18, 2023

Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr

Profit after tax (before exceptional items) up 23% to Rs 215 crores


Glenmark receives ANDA approval for Apremilast Tablets
Drug Approval | October 18, 2023

Glenmark receives ANDA approval for Apremilast Tablets

Glenmark's current portfolio consists of 188 products authorized for distribution in the US


Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site
News | October 17, 2023

Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site

Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening


Lupin enters into BTA with Lupin Manufacturing Solutions
News | October 17, 2023

Lupin enters into BTA with Lupin Manufacturing Solutions

Lupin enters into BTA with Lupin Manufacturing Solutions